Clark C E, Clyman R I, Roth R S, Sniderman S H, Lane B, Ballard R A
J Pediatr. 1981 Oct;99(4):625-8. doi: 10.1016/s0022-3476(81)80276-4.
Sixty of 63 newborn infants weighing less than 1,250 gm, admitted consecutively to the Intensive Care Nursery during a 15-month period, were prospectively investigated for the incidence of intraventricular hemorrhage by early computerized tomography or by autopsy. Nineteen of the 60 infants had evidence of IVH. The incidence of IVH was correlated with the presence of possible neonatal, obstetrical, asphyxial, or therapeutic risk factors. There was a significant difference in only one of the risk factors: birth outside the perinatal center. Fifteen of 27 outborn infants (56%) developed IVH, whereas only four of 33 inborn infants (12%) developed IVH (P less than 0.001). There were no statistically significant differences in maternal obstetrical risk factors, infant risk factors, or indices of birth asphyxia in the inborn compared with the outborn infants. However, perinatal therapeutic risk factors differed between the two groups. Outborn infants were less likely to have received betamethasone (P less than 0.001), were less likely to have their arterial blood gases monitored and stabilized during the first 20 minutes after birth (P less than 0.001), and were given more bicarbonate (P less than 0.001) and more boluses of fluid intravenously (P less than 0.02). The risk of IVH in very low birth-weight infants may be significantly decreased by therapeutic factors at birth. Maternal transport to a perinatal center and intensive neonatal resuscitation may contribute to decreasing the incidence of intraventricular hemorrhage.
在15个月期间,连续入住重症监护病房的63名体重不足1250克的新生儿中,有60名通过早期计算机断层扫描或尸检对脑室内出血的发生率进行了前瞻性研究。60名婴儿中有19名有脑室内出血的证据。脑室内出血的发生率与可能存在的新生儿、产科、窒息或治疗风险因素相关。只有一个风险因素存在显著差异:在围产期中心以外出生。27名外出生婴儿中有15名(56%)发生脑室内出血,而33名内出生婴儿中只有4名(12%)发生脑室内出血(P<0.001)。与外出生婴儿相比,内出生婴儿的母亲产科风险因素、婴儿风险因素或出生窒息指标没有统计学上的显著差异。然而,两组之间的围产期治疗风险因素有所不同。外出生婴儿接受倍他米松治疗的可能性较小(P<0.001),出生后前20分钟内监测和稳定动脉血气的可能性较小(P<0.001),给予的碳酸氢盐更多(P<0.001),静脉注射的液体推注量更多(P<0.02)。出生时的治疗因素可能会显著降低极低出生体重婴儿发生脑室内出血的风险。产妇转运至围产期中心和强化新生儿复苏可能有助于降低脑室内出血的发生率。